C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 4 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Recs

0
Player Avatar Roni13 (20.34) Submitted: 5/16/2010 7:14:01 AM : Outperform Start Price: $82.01 BCR Score: +6.05

too cheap for its growth and fantastic balance sheet

Featured Broker Partners


Advertisement